VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 25, 2007) - Med BioGene Inc. (TSX VENTURE:MBI), a life science company focused on the development and commercialization of genomic-based diagnostic and screening tests for cancer and cardiovascular disease, is pleased to announce that it has engaged JRG Ventures, LLC (www.jrgventures.com) as its strategic business advisors.
